Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Glenmark Pharmaceuticals Limited

GLENMARK.NS Technical Analysis Summary (NSE)

Analyze GLENMARK.NS on the NSE with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

GLENMARK.NS●NSE
HealthcareDrug Manufacturers - Specialty & Generic
₹2282.30
₹28.70(1.24%)
Indian Market opens in 1h 27m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

GLENMARK.NS Technical Analysis Summary (NSE)

Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS) stock currently shows a bearish trend on the NSE, supported by momentum and weak buying pressure.

Overall Sentiment:Sell
Momentum:Bearish to Weak (RSI: 39.65)
Trend Strength:Moderate (ADX: 21.16)
Volatility:Medium (ATR: 65.63)
Support/Resistance:$2274.82 – $2515.86 (Bollinger Bands)

Technical conditions suggest Glenmark Pharmaceuticals Limited on the NSE is awaiting a decisive move. This mix signals that Glenmark Pharmaceuticals Limited is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 39.65

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 10.81

Bullish
Oversold zone signals rebound potential.

Williams %R: -95.79

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -5.30

Strongly Bearish
Sharp downside momentum.

Takeaway:Glenmark Pharmaceuticals Limited shows strong bearish momentum, signaling downside pressure.

Trend & Volatility

MACD: -20.76

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 21.16

Moderate
Moderate trend, direction gaining strength.

ATR (14): 65.63

Rising
Rising volatility, market activity increasing.

CCI (14): -110.62

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:Glenmark Pharmaceuticals Limited shows oversold trend conditions, with potential for rebound if buyers step in.

Support & Resistance indicators
Bollinger Bands
Upper Band
$2515.86
Middle Band (SMA 20)
$2395.34
Lower Band
$2274.82
Current Position
Within Bands

Takeaway:Glenmark Pharmaceuticals Limited trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$2503.83
Middle Line (EMA 20)
$2372.57
Lower Channel
$2241.32
Squeeze Status
Squeeze On

Takeaway:Glenmark Pharmaceuticals Limited trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume803.11K
Money Flow Index37.55Bearish, selling pressure outweighs inflows.
Relative Vigor Index34.06Bearish, price momentum favors sellers.

Overall Takeaway:GLENMARK.NS shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS), here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Glenmark Pharmaceuticals Limited shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.

(NSE: GLENMARK.NS) Technical Analysis FAQ